{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:29:45Z","timestamp":1788348585781,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The literature lacks well-established benchmarks for expected time between screening mammogram to diagnostic imaging and then to core needle breast biopsy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Timeliness of diagnostic imaging workup was evaluated using aggregate data from 2005 to 2019 submitted to The National Quality Measures for Breast Centers (NQMBC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 419 breast centers submitted data for 1,805,515 patients on the time from screening mammogram to diagnostic imaging. The overall time was 7 days with 75th, 25th, and 10th percentile values of 5, 10, and 13.5 days, respectively. The average time in business days decreased from 9.1 to 7.1 days (<jats:italic>p\u2009<\/jats:italic>&lt;\u20090.001) over the study period with the greatest gains in poorest-performing quartiles. Screening centers and centers in the Midwest had significantly shorter time to diagnostic imaging. Time from diagnostic imaging to core needle biopsy was submitted by 406 facilities representing 386,077 patients. The average time was 6 business days, with 75th, 25th, and 10th percentiles of 4, 9, and 13.7 days, respectively. Time to biopsy improved from a mean of 9.0 to 6.3 days (<jats:italic>p\u2009<\/jats:italic>&lt;\u20090.001) with the most improvement in the poorest-performing quartiles. Screening centers, centers in the Midwest, and centers in metropolitan areas had significantly shorter time to biopsy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In a robust dataset, the time from screening mammogram to diagnostic imaging and from diagnostic imaging to biopsy decreased from 2005 to 2019. On average, patients could expect to have diagnostic imaging and biopsies within 1 week of abnormal results. Monitoring and comparing performance with reported data may improve quality in breast care.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-023-13905-6","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T20:26:16Z","timestamp":1690921576000},"page":"6070-6078","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Timeliness of Breast Diagnostic Imaging and Biopsy in Practice: 15 Years of Collecting, Comparing, and Defining Quality Breast Cancer Care"],"prefix":"10.1245","volume":"30","author":[{"given":"Cory Amanda","family":"Donovan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary S.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayfer Kamali","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Sarantou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"key":"13905_CR1","volume-title":"Ensuring quality cancer care","author":"M Hewitt","year":"1999","unstructured":"Hewitt M, Simone JV. Ensuring quality cancer care. Washington, DC: National Academies Press; 1999."},{"issue":"3","key":"13905_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/jamaoncol.2015.4508","volume":"2","author":"RJ Bleicher","year":"2016","unstructured":"Bleicher RJ, Ruth K, Sigurdson ER, et al. Time to surgery and breast cancer survival in the united states. JAMA Oncol. 2016;2(3):330\u20139. https:\/\/doi.org\/10.1001\/jamaoncol.2015.4508.","journal-title":"JAMA Oncol"},{"key":"13905_CR3","doi-asserted-by":"publisher","first-page":"m4087","DOI":"10.1136\/bmj.m4087","volume":"371","author":"TP Hanna","year":"2020","unstructured":"Hanna TP, King WD, Thibodeau S, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020;371:m4087. https:\/\/doi.org\/10.1136\/bmj.m4087.","journal-title":"BMJ"},{"issue":"10","key":"13905_CR4","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1245\/s10434-019-07566-7","volume":"20","author":"AR Kupstas","year":"2019","unstructured":"Kupstas AR, Hoskin TL, Day CN, et al. Effect of surgery type on time to adjuvant chemotherapy and impact of delay on breast cancer survival: a National Cancer Database Analysis. Ann Surg Oncol. 2019;20(10):3240\u20139. https:\/\/doi.org\/10.1245\/s10434-019-07566-7.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"13905_CR5","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.jacr.2016.03.010","volume":"13","author":"RC Mayo III","year":"2016","unstructured":"Mayo RC III, Parikh JR. Breast imaging: the face of imaging 3.0. J Am Coll Radiol. 2016;13(8):1003\u20137.","journal-title":"J Am Coll Radiol"},{"issue":"1 Pt 12","key":"13905_CR6","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.jacr.2016.09.008","volume":"13","author":"CB Weldon","year":"2016","unstructured":"Weldon CB, Friedenwald SM, Kulkarni SA. Radiology as the point of cancer patient and care team engagement: applying the 4R model at a patient\u2019s breast cancer care initiation. J Am Coll Radiol. 2016;13(1 Pt 12):1579\u201389. https:\/\/doi.org\/10.1016\/j.jacr.2016.09.008.","journal-title":"J Am Coll Radiol"},{"issue":"4","key":"13905_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jamcollsurg.2010.01.015","volume":"210","author":"J Landercasper","year":"2010","unstructured":"Landercasper J, Linebarger JH, Ellis RL, et al. A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center. J Am Coll Surg. 2010;210(4):449\u201355. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2010.01.015.","journal-title":"J Am Coll Surg"},{"issue":"11","key":"13905_CR8","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.jacr.2020.07.019","volume":"17","author":"GH Rauscher","year":"2020","unstructured":"Rauscher GH, Tossas-Milligan T, Macarol T, Grabler PM, Murphy AM. Trends in attaining mammography quality benchmarks with repeated participation in a quality measurement program: going beyond the Mammography Quality Standards Act to address breast cancer disparities. J Am Coll Radiol. 2020;17(11):1420\u20138. https:\/\/doi.org\/10.1016\/j.jacr.2020.07.019.","journal-title":"J Am Coll Radiol"},{"key":"13905_CR9","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1245\/s10434-018-07108-7","volume":"26","author":"ME Miller","year":"2019","unstructured":"Miller ME, Bleicher RJ, Kaufman CS, et al. Impact of breast center accreditation on compliance with breast quality performance measures at Commission on Cancer- accredited centers. Ann Surg Oncol. 2019;26:1202\u201311. https:\/\/doi.org\/10.1245\/s10434-018-07108-7.","journal-title":"Ann Surg Oncol"},{"key":"13905_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1200\/JOP.211.000413","volume":"8","author":"LM Quan","year":"2012","unstructured":"Quan LM, Shumak RS, Majpruz V, Holloway CMD, O\u2019Malley FP, Chiarelli AM. Improving work-up of the abnormal mammogram through organized assessment: results from the Ontario Breast Screening Program. J Oncol Pract. 2012;8:107\u201312. https:\/\/doi.org\/10.1200\/JOP.211.000413.","journal-title":"J Oncol Pract"},{"key":"13905_CR11","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.2015\/AJPH.2009.160184","volume":"100","author":"LC Richardson","year":"2010","unstructured":"Richardson LC, Royalty J, Howe W, Helsel W, Kammerer W, Benard VB. Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996\u20132005. Am J Publ Health. 2010;100:1769\u201375. https:\/\/doi.org\/10.2015\/AJPH.2009.160184.","journal-title":"Am J Publ Health"},{"key":"13905_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1245\/s10434-009-0729-5","volume":"17","author":"CS Kaufman","year":"2010","unstructured":"Kaufman CS, Shockney L, Rabinowitz, et al. National quality measures for breast centers (NQMBC): a robust quality tool: breast center quality measures. Ann Surg Oncol. 2010;17:377\u201385. https:\/\/doi.org\/10.1245\/s10434-009-0729-5.","journal-title":"Ann Surg Oncol"},{"key":"13905_CR13","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1001\/jama.294.14.1788","volume":"294","author":"MB Rosenthal","year":"2005","unstructured":"Rosenthal MB, Frank RG, Li A, Epstein AM. Early experience with pay-for-performance: from concept to practice. JAMA. 2005;294:1788\u201393.","journal-title":"JAMA"},{"issue":"Suppl 1","key":"13905_CR14","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.6004\/jnccn.2014.0204","volume":"12","author":"SB Edge","year":"2014","unstructured":"Edge SB. The NCCN guidelines program and opportunities for quality improvement. J Natl Compr Cancer Netw. 2014;12(Suppl 1):S1-4.","journal-title":"J Natl Compr Cancer Netw"},{"key":"13905_CR15","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1245\/s10434-014-4086-7","volume":"22","author":"E Liederback","year":"2015","unstructured":"Liederback E, Sisco M, Wang C, et al. Wait times for breast surgical operations. 2003\u20132011: a report from the National Cancer Data Base. Ann Surg Oncol. 2015;22:899\u2013907.","journal-title":"Ann Surg Oncol"},{"key":"13905_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/sj.bjc.6603523","volume":"96","author":"N Saint-Jacques","year":"2007","unstructured":"Saint-Jacques N, Younis T, Dewar R, Rayson D. Wait times for breast cancer care. Br J Cancer. 2007;96:162\u20138.","journal-title":"Br J Cancer"},{"issue":"10","key":"13905_CR17","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1245\/s10434-016-5486-7","volume":"23","author":"AC Polverini","year":"2016","unstructured":"Polverini AC, Nelson RA, Marcinkowski E, et al. Time to treatment: measuring quality breast cancer care. Ann Surg Oncol. 2016;23(10):3392\u2013402. https:\/\/doi.org\/10.1245\/s10434-016-5486-7.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"13905_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2648.2009.05210.x2010","volume":"66","author":"S Drageset","year":"2010","unstructured":"Drageset S, Lindstr\u00f8m TC, Underlid K. Coping with breast cancer: between diagnosis and surgery. J Adv Nurs. 2010;66(1):149\u201358. https:\/\/doi.org\/10.1111\/j.1365-2648.2009.05210.x2010.","journal-title":"J Adv Nurs"},{"issue":"1","key":"13905_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1037\/0278-6133.23.1.42","volume":"23","author":"BD Heckman","year":"2004","unstructured":"Heckman BD, Fisher EB, Monsees B, Merbaum M, Ristvedt S, Bishop C. Coping and anxiety in women recalled for additional diagnostic procedures following an abnormal screening mammogram. Health Psychol. 2004;23(1):42\u20138. https:\/\/doi.org\/10.1037\/0278-6133.23.1.42.","journal-title":"Health Psychol"},{"key":"13905_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/jncimono\/1997.22.131","volume":"22","author":"BK Rimer","year":"1997","unstructured":"Rimer BK, Bluman LG. The psychosocial consequences of mammography. J Natl Cancer Inst Monogr. 1997;22:131\u20138.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"13905_CR21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/pubmed\/23.4.292","volume":"23","author":"J Bret","year":"2001","unstructured":"Bret J, Austoker J, Onc G. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-center follow-up study comparing different breast screening result groups five months after their last breast screening appointment. J Pub Health Med. 2001;23:292\u2013300.","journal-title":"J Pub Health Med"},{"issue":"9","key":"13905_CR22","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1111\/tbj.13953","volume":"26","author":"JC Bekeny","year":"2020","unstructured":"Bekeny JC, Luvisa K, Wirth P, et al. Critical evaluation of factors contributing to time to mastectomy within a single health care system. Breast J. 2020;26(9):1702\u201311. https:\/\/doi.org\/10.1111\/tbj.13953.","journal-title":"Breast J."},{"issue":"14","key":"13905_CR23","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/jnci\/djp176","volume":"101","author":"I Menashe","year":"2009","unstructured":"Menashe I, Anderson WF, Jatoi I, Rosenberg PS. Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst. 2009;101(14):993\u20131000.","journal-title":"J Natl Cancer Inst."},{"key":"13905_CR24","first-page":"922","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","unstructured":"Centers for Disease Control and Prevention. Vital signs: racial disparities in breast cancer severity\u2014United Stages, 2005\u20132009. Morbid Mortal Wkly Rep. 2012;61:922\u20136.","journal-title":"Morbid Mortal Wkly Rep"},{"issue":"3","key":"13905_CR25","doi-asserted-by":"publisher","first-page":"e185113","DOI":"10.1001\/jamasurg.2018.5113","volume":"154","author":"YL Eaglehous","year":"2019","unstructured":"Eaglehous YL, Georg MW, Shriver CD, Zhu K. Racial differences in time to breast cancer surgery and overall survival in the US military health system. JAMA Surg. 2019;154(3):e185113.","journal-title":"JAMA Surg"},{"issue":"9","key":"13905_CR26","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1245\/s10434-015-4397-3","volume":"22","author":"VA Sheppard","year":"2015","unstructured":"Sheppard VA, Oppong BA, Hampton R, et al. Disparities in breast cancer surgery delay: the lingering effect of race. Ann Surg Oncol. 2015;22(9):2902\u201329011.","journal-title":"Ann Surg Oncol"},{"key":"13905_CR27","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.3390\/curroncol28060405","volume":"28","author":"RL Walsh","year":"2021","unstructured":"Walsh RL, Lofters A, Moineddin R, Kryzanowska M, Grunfeld E. Primary care continuity and wait times to receiving breast cancer chemotherapy: a population-based retrospective cohort study using CanIMPACT data. Curr Oncol. 2021;28:4786\u2013804. https:\/\/doi.org\/10.3390\/curroncol28060405.","journal-title":"Curr Oncol"},{"issue":"10","key":"13905_CR28","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1111\/tbj.14046","volume":"26","author":"S Valente","year":"2020","unstructured":"Valente S, Al-Hilli Z, Liu Y, Greve N, Tu C, Grobmyer SR. Association of patient factors with time to treatment for breast cancer. Breast J. 2020;26(10):1995\u20132001. https:\/\/doi.org\/10.1111\/tbj.14046.","journal-title":"Breast J"},{"issue":"11","key":"13905_CR29","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/jamasurg.2013.3738","volume":"148","author":"CL Kvasnovsky","year":"2013","unstructured":"Kvasnovsky CL, Kesmodel AB, Gargasin JL, et al. Expansion of screening mammography in the Veterans Health Administration: implications for breast cancer treatment. JAMA Surg. 2013;148(11):999\u20131004. https:\/\/doi.org\/10.1001\/jamasurg.2013.3738.","journal-title":"JAMA Surg"},{"issue":"1","key":"13905_CR30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.juro.2013.01.018","volume":"190","author":"JT Casey","year":"2013","unstructured":"Casey JT, Berkowitz L, Cashy J, Wichramasinghe N, Schaeffer A, Gonzalez C. A protocol based, electronic medical record enabled care coordination system improves the timeliness and efficiency of care for patients with hematuria. J Urol. 2013;190(1):212\u20137. https:\/\/doi.org\/10.1016\/j.juro.2013.01.018.","journal-title":"J Urol"},{"issue":"10","key":"13905_CR31","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1245\/s10434-019-07558-7","volume":"26","author":"A Laws","year":"2019","unstructured":"Laws A, Crocker A, Dort J, et al. Improving wait times and patient experience through implementation of a provincial expedited diagnostic pathway for BI-RADS 5 breast lesions. Ann Surg Oncol. 2019;26(10):3361\u20137. https:\/\/doi.org\/10.1245\/s10434-019-07558-7.","journal-title":"Ann Surg Oncol"},{"key":"13905_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s43018-020-0074-y","volume":"1","author":"M Richards","year":"2020","unstructured":"Richards M, Anderson M, Carter P, et al. The impact of COVID-19 pandemic on cancer care. Nat Cancer. 2020;1:565\u20137.","journal-title":"Nat Cancer"},{"key":"13905_CR33","doi-asserted-by":"publisher","first-page":"e061121","DOI":"10.1136\/bmjopen-2022-061121","volume":"12","author":"K Morrill","year":"2022","unstructured":"Morrill K, Robles-Morales R, Lopez-Pentacost M, et al. Factors associated with cancer treatment delay: a protocol for systematic review and meta-analysis. BMJ Open. 2022;12:e061121. https:\/\/doi.org\/10.1136\/bmjopen-2022-061121.","journal-title":"BMJ Open"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13905-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-13905-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13905-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T14:05:31Z","timestamp":1694441131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-13905-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["13905"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-13905-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]},"assertion":[{"value":"1 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}